Mirae Asset Global Investments Co., Ltd. Myriad Genetics Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,702 shares of MYGN stock, worth $77,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,702

Previous 334,717 99.19%

Holding current value

$77,277

Previous $7.14 Million 99.08%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$17.98 - $25.47 $5.97 Million - $8.46 Million	-332,015 Reduced 99.19%	2,702 $66,000
Q1 2024 May 01, 2024	BUY	$17.59 - $23.59 $2.63 Million - $3.52 Million	149,234 Added 80.46%	334,717 $7.14 Million
Q4 2023 Jan 24, 2024	SELL	$13.91 - $21.32 $3.18 Million - $4.87 Million	-228,288 Reduced 55.17%	185,483 $3.55 Million
Q3 2023 Oct 26, 2023	BUY	$15.99 - $23.22 $524,839 - $762,150	32,823 Added 8.62%	413,771 $6.64 Million
Q2 2023 Aug 10, 2023	BUY	$17.56 - $23.76 $798,312 - $1.08 Million	45,462 Added 13.55%	380,948 $8.83 Million
Q1 2023 May 04, 2023	BUY	$15.26 - $23.75 $153,576 - $239,020	10,064 Added 3.09%	335,486 $7.79 Million
Q4 2022 Feb 09, 2023	SELL	$14.51 - $20.99 $1.08 Million - $1.56 Million	-74,151 Reduced 18.56%	325,422 $4.72 Million
Q3 2022 Nov 10, 2022	BUY	$18.21 - $27.88 $948,722 - $1.45 Million	52,099 Added 14.99%	399,573 $7.62 Million
Q2 2022 Jul 26, 2022	BUY	$16.45 - $25.88 $1.77 Million - $2.78 Million	107,368 Added 44.72%	347,474 $6.31 Million
Q1 2022 May 10, 2022	SELL	$22.67 - $28.01 $1.01 Million - $1.25 Million	-44,553 Reduced 15.65%	240,106 $6.05 Million
Q4 2021 Feb 08, 2022	BUY	$24.13 - $32.63 $1.48 Million - $2.01 Million	61,532 Added 27.58%	284,659 $7.86 Million
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $1.32 Million - $1.61 Million	43,986 Added 24.55%	223,127 $7.21 Million
Q2 2021 Aug 11, 2021	BUY	$25.39 - $32.61 $228,459 - $293,424	8,998 Added 5.29%	179,141 $5.48 Million
Q1 2021 May 13, 2021	BUY	$19.92 - $31.6 $1.44 Million - $2.29 Million	72,491 Added 74.23%	170,143 $5.18 Million
Q4 2020 Feb 10, 2021	BUY	$12.16 - $19.77 $270,438 - $439,684	22,240 Added 29.49%	97,652 $1.93 Million
Q3 2020 Nov 12, 2020	BUY	$11.25 - $14.75 $264,870 - $347,274	23,544 Added 45.39%	75,412 $984,000
Q2 2020 Aug 11, 2020	BUY	$10.69 - $16.49 $554,468 - $855,303	51,868 New	51,868 $589,000

Others Institutions Holding MYGN

# of Institutions

232

Shares Held

92.6M

Call Options Held

117K

Put Options Held

113K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Myriad Genetics Inc Transaction History